The announcement came one day after Celgene itself agreed to be acquired by another major drug company, Bristol-Myers Squibb Co., for $74 billion. Celgene, based in Summit, N.J., produces drugs such as the blood-cancer therapy Revlimid.

Source: Los Angeles Times January 06, 2019 19:41 UTC